4//SEC Filing
SETH SANDESH 4
Accession 0001213900-22-036868
CIK 0001388320other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:13 PM ET
Size
5.5 KB
Accession
0001213900-22-036868
Insider Transaction Report
Form 4
SETH SANDESH
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01+827,366→ 827,366 totalExercise: $4.96Exp: 2032-07-01→ Common Stock (827,366 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant.
- [F2]Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001566175
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 7:13 PM ET
- Size
- 5.5 KB